Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EXELIXIS, INC.

(EXEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Therapeutic Drugs
12:35pPfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
MT
07:10aPfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults
MT
07:08aPfizer, BioNTech Start Clinical Study On Omicron-based Vaccine
MT
07:00aSierra Oncology's bone marrow cancer drug meets study main goal
RE
04:31aGermany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/24U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments
RE
01/24U.S. FDA to restrict use of Regeneron, Lilly COVID antibody drugs - WaPo
RE
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24FDA to Restrict Monoclonal Antibodies Manufactured by Eli Lilly, Regeneron Pharmaceutic..
MT
01/24Pfizer-BioNTech Booster Shot Effective Against Omicron, New Study Finds
MT
01/24UK to begin testing Merck's COVID pill for hospitalized patients
RE
01/24Gilead Secures FDA Approval for Veklury in Non-Hospitalized COVID-19 Patients at High R..
MT
01/24Israeli Study Finds Fourth Vaccine Dose Increases Resistance To COVID-19 In People Over..
MT
01/21Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients
DJ
01/21Gilead Sciences, Inc. Announces FDA Approves Veklury« for the Treatment of Non-Hospital..
CI
01/21UBS Adjusts BioNTech SE Price Target to $170 From $300, Maintains Neutral Rating
MT
01/21GSK, Vir ramping up U.S. output of COVID antibody drug
RE
01/21Pfizer-BioNTech's COVID-19 Vaccine Gets WHO Backing for Kids 5 to 11 Years Old
MT
01/21European ADRs Move Lower in Friday Trading
MT
01/21Japan OKs Pfizer/BioNTech's COVID-19 Vaccine For Children
MT
01/21Japan Clears Use of Pfizer's COVID-19 Vaccine on Children
MT
01/20ANALYST RECOMMENDATIONS : Activision Blizzard, AMD, Bumble, Etsy, Ford...
01/20BMO Capital Lifts Vertex Pharmaceuticals to Outperform From Market Perform, Price Targe..
MT
01/19SiteOne Therapeutics Announces Collaboration and License Agreement with Vertex Pharmace..
CI
01/19Regeneron Says US FDA Accepts for Review its Supplemental BLA for Libtayo in Combinatio..
MT
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19FDA Accepts for Review Libtayo« (cemiplimab-rwlc) in Combination with Chemotherapy for ..
CI
01/19ANALYST RECOMMENDATIONS : Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs..
01/19BIONTECH : Goldman Sachs sticks Neutral
MD
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
01/19Sanofi-Regeneron's Dermatitis Drug Lowers Itch, Skin Lesions In Late-Stage Trial
MT
01/18Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud..
MT
01/18Gilead says counterfeit HIV drugs ended up with patients
RE
01/18Morgan Stanley Lowers Price Target for Gilead Sciences to $72 From $74, Maintains Equal..
MT
01/18Gilead says counterfeiting network sold $250 mln worth of its HIV drugs
RE
01/18Morgan Stanley Adjusts Regeneron Pharmaceuticals Price Target to $585 From $617, Mainta..
MT
01/18Morgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/13WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
RE
01/13European ADRs Move Higher in Thursday Trading
MT
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/13Countryside Slumps 17% as CEO Steps Down Amid Deal with Activist Investor
MT
01/13Countryside Properties CEO Steps Down; Chair Named As Interim Successor
MT
01/12Pfizer's Pneumonia Jab, COVID-19 Booster Shot Safe for Coadministration in Late-Stage S..
MT
01/12BIONTECH : Goldman Sachs reaffirms its Neutral rating
MD
01/12Pfizer Says Pneumococcal Vaccine Combined with COVID-19 Shot Effective in Adults Above ..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on EXELIXIS, INC.